Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,714.00
Bid: 1,713.50
Ask: 1,714.50
Change: 9.00 (0.53%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,714.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Mining rebound lifts markets higher

Fri, 19th Apr 2013 11:57

The FTSE 100 rebound on Friday morning after a five-day losing streak as strong gains in the mining sector lifted London's benchmark higher."Clients who went bargain hunting in the mining space after the aggressive sell-off earlier in the week have been rewarded this morning, as the sector bounces back strongly early on," said Matt Basi, the Head of UK Sales Trading at CMC Markets.Ahead of today's session, the FTSE 100 had lost 2.7% of its value after five consecutive falls as disappointing US earnings and concerns over global growth weighed on sentiment.First-quarter economic gross domestic product figures from China, a plummeting gold price and downwards revisions to global growth forecasts by the International Monetary Fund caused some volatile swings in the mining sector earlier this week. Before today, FTSE 350 mining stocks had fallen by an average 9.14% since last Friday.FTSE 100: Miners provide a liftMining stocks were performing well after a volatile week for the sector. ENRC, Vedanta, EVRAZ and Randgold were all making decent gains by lunchtime.Anglo American was also a high riser after announcing that production at its larger operations of iron ore and copper increased in the first quarter, when compared with last year, despite the company scaling back spending.Meanwhile, telecoms firm Vodafone was also in demand as rumours continue to circulate surrounding a buy-out of its 45% stake in its US wireless joint venture with Verizon. According to reports this morning, a deal could happen this year as fears about tax obstacles ease.GlaxoSmithKline was trading lower ahead of its first-quarter update next week. There were reports this morning that the company is being investigated over claims it paid off firms to delay the launch of cheap versions of its anti-depression drug.FTSE 250: Spectris plummets after weak first quarterSpectris, the electrical engineering firm, plummeted after reporting an 8.0% fall in first-quarter sales, reflecting a deferral of orders and shipment delaysHigh Street bookie William Hill surged early on despite reporting that growth had moderated during the first quarter. The firm did say however that the Grand National after the quarter-end was a "major success", beating its record win achieved on the race in 2009.Online information and events group Euromoney fell after announced that it has acquired a 75% stake in the Australian provider of investment forums, Centre for Investor Education.
More News
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.